Apixaban Versus Dual-antiplatelet Therapy (Clopidogrel and Aspirin) in Acute Non-disabling Cerebrovascular Events "ADANCE"

Not yet recruiting

Phase 2/3 Results N/A

References

Sources for Trial Information